| 1 |
Martinez FD, Vercelli D. Asthma. Lancet 2013;382:1360-1372.
DOI
ScienceOn
|
| 2 |
Lotvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011;127:355-360.
DOI
ScienceOn
|
| 3 |
Global Strategy for Asthma Management and Prevention: 2014 Global Initiative for Asthma (GINA) [Internet]. Vancouver: Global Initiative for Asthma, c2014 [cited 2014]. Available from: http://www.ginasthma.org., Data last updated. 2014
|
| 4 |
Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008;32:545-554.
DOI
ScienceOn
|
| 5 |
Aroni R, Goeman D, Stewart K, et al. Enhancing validity: what counts as an asthma attack? J Asthma 2004;41:729-737.
DOI
ScienceOn
|
| 6 |
Haselkorn T, Fish JE, Zeiger RS, et al. Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) Study. J Allergy Clin Immunol 2009;124:895-902.e1-4.
DOI
ScienceOn
|
| 7 |
Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149(3 Pt 1):604-610.
DOI
ScienceOn
|
| 8 |
Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation to inhaled corticosteroid use. JAMA 1992;268:3462-3464.
DOI
ScienceOn
|
| 9 |
Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011;105:930-938.
DOI
ScienceOn
|
| 10 |
Osborne ML, Pedula KL, O'Hollaren M, et al. Assessing future need for acute care in adult asthmatics: the Profile of Asthma Risk Study: a prospective health maintenance organization-based study. Chest 2007;132:1151-1161.
DOI
ScienceOn
|
| 11 |
Burks AW, Tang M, Sicherer S, et al. ICON: food allergy. J Allergy Clin Immunol 2012;129:906-920.
DOI
ScienceOn
|
| 12 |
Sturdy PM, Victor CR, Anderson HR, et al. Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study. Thorax 2002;57:1034-1039.
DOI
|
| 13 |
Fitzpatrick S, Joks R, Silverberg JI. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults. Clin Exp Allergy 2012;42:747-759.
DOI
ScienceOn
|
| 14 |
Pawankar R, Bunnag C, Khaltaev N, Bousquet J. Allergic rhinitis and its impact on asthma in Asia Pacific and the ARIA update 2008. World Allergy Organ J 2012;5(Suppl 3):S212-217.
DOI
|
| 15 |
Belda J, Giner J, Casan P, Sanchis J. Mild exacerbations and eosinophilic inflammation in patients with stable, well-controlled asthma after 1 year of follow-up. Chest 2001;119:1011-1017.
DOI
ScienceOn
|
| 16 |
Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax 2006;61:169-176.
DOI
ScienceOn
|
| 17 |
Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for near-fatal asthma: a case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med 1998;157(6 Pt 1):1804-1809.
DOI
ScienceOn
|
| 18 |
Miller MK, Lee JH, Miller DP, Wenzel SE; TENOR Study Group. Recent asthma exacerbations: a key predictor of future exacerbations. Respir Med 2007;101:481-489.
DOI
ScienceOn
|
| 19 |
O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:19-24. Erratum in: Am J Respir Crit Care Med 2010;182:983-984.
DOI
ScienceOn
|
| 20 |
Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126:213-219.
DOI
ScienceOn
|
| 21 |
Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-1200.
DOI
ScienceOn
|
| 22 |
Ulrik CS. Outcome of asthma: longitudinal changes in lung function. Eur Respir J 1999;13:904-918.
DOI
|
| 23 |
Foster JM, Aucott L, van der Werf RH, et al. Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis. Respir Med 2006;100:1318-1336.
DOI
ScienceOn
|
| 24 |
Rosi E, Stendardi L, Binazzi B, Scano G. Perception of airway obstruction and airway inflammation in asthma: a review. Lung 2006;184:251-258.
DOI
|
| 25 |
Zeiger RS, Baker JW, Kaplan MS, et al. Variability of symptoms in mild persistent asthma: baseline data from the MIAMI Study. Respir Med 2004;98:898-905.
DOI
ScienceOn
|
| 26 |
Bateman ED, Harrison TW, Quirce S, et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011;12:38.
DOI
ScienceOn
|
| 27 |
Meltzer EO, Busse WW, Wenzel SE, et al. Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation. J Allergy Clin Immunol 2011;127:167-172.
DOI
ScienceOn
|
webmaster
